Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India

Abstract Background Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associate...

Full description

Bibliographic Details
Main Authors: Ashish Pathak, Andreas Mårtensson, Sudhir Gawariker, Ashish Sharma, Vishal Diwan, Manju Purohit, Johan Ursing
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-020-03274-w
_version_ 1818112716889391104
author Ashish Pathak
Andreas Mårtensson
Sudhir Gawariker
Ashish Sharma
Vishal Diwan
Manju Purohit
Johan Ursing
author_facet Ashish Pathak
Andreas Mårtensson
Sudhir Gawariker
Ashish Sharma
Vishal Diwan
Manju Purohit
Johan Ursing
author_sort Ashish Pathak
collection DOAJ
description Abstract Background Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. Methods Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. Results Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. Conclusion The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use.
first_indexed 2024-12-11T03:23:22Z
format Article
id doaj.art-c943624b91744d7896737b70c0b76143
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-11T03:23:22Z
publishDate 2020-08-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-c943624b91744d7896737b70c0b761432022-12-22T01:22:35ZengBMCMalaria Journal1475-28752020-08-011911710.1186/s12936-020-03274-wStable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, IndiaAshish Pathak0Andreas Mårtensson1Sudhir Gawariker2Ashish Sharma3Vishal Diwan4Manju Purohit5Johan Ursing6Department of Pediatrics, R D Gardi Medical CollegeDepartment of Women and Children’s Health, International Maternal and Child Health Unit, Uppsala UniversityDepartment of Medicine, R D Gardi Medical CollegeDepartment of Medicine, R D Gardi Medical CollegeDepartment of Women and Children’s Health, International Maternal and Child Health Unit, Uppsala UniversityGlobal Health–Health Systems and Policy: Medicines, Focusing Antibiotics, Department of Global Public Health, Karolinska InstitutetDepartment of Infectious Diseases, Danderyd HospitalAbstract Background Artesunate plus sulfadoxine–pyrimethamine (ASP) is first-line treatment for uncomplicated Plasmodium falciparum malaria in most of India, except for six North-eastern provinces where treatment failure rates were high. In Ujjain, central India, the frequency of mutations associated with increased drug tolerance, but not overt resistance to sulfadoxine and pyrimethamine were 9% and > 80%, respectively, in 2009 and 2010, just prior to the introduction of ASP. The frequency of drug resistance associated mutations in Ujjain in 2015–2016 after 3–4 years of ASP use, are reported. Methods Blood samples from patients with P. falciparum mono-infection verified by microscopy were collected on filter-paper at all nine major pathology laboratories in Ujjain city. Codons pfdhfr 16–185, pfdhps 436–632 and K13 407–689 were identified by sequencing. Pfcrt K76T and pfmdr1 N86Y were identified by restriction fragment length polymorphism. Results Sulfadoxine–pyrimethamine resistance-associated pfdhfr 108 N and 59R alleles were found in 100/104 (96%) and 87/91 (96%) samples, respectively. Pfdhps 437G was found in 10/105 (10%) samples. Double mutant pfdhfr 59R + 108 N were found in 75/81 (93%) samples. Triple mutant pfdhfr 59R + 108 N and pfdhps 437G were found in 6/78 (8%) samples. Chloroquine-resistance-associated pfcrt 76T was found in 102/102 (100%). Pfmdr1 N86 and 86Y were identified in 83/115 (72%) and 32/115 (28%) samples, respectively. Conclusion The frequency of P. falciparum with reduced susceptibility to sulfadoxine–pyrimethamine remained high, but did not appear to have increased significantly since the introduction of ASP. No polymorphisms in K13 associated with decreased artemisinin susceptibility were found. ASP probably remained effective, supporting continued ASP use.http://link.springer.com/article/10.1186/s12936-020-03274-wPlasmodium falciparumArtesunate sulfadoxine pyrimethamineChloroquineResistancepfcrtpfmdr1
spellingShingle Ashish Pathak
Andreas Mårtensson
Sudhir Gawariker
Ashish Sharma
Vishal Diwan
Manju Purohit
Johan Ursing
Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
Malaria Journal
Plasmodium falciparum
Artesunate sulfadoxine pyrimethamine
Chloroquine
Resistance
pfcrt
pfmdr1
title Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_full Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_fullStr Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_full_unstemmed Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_short Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
title_sort stable high frequencies of sulfadoxine pyrimethamine resistance associated mutations and absence of k13 mutations in plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine pyrimethamine in ujjain madhya pradesh india
topic Plasmodium falciparum
Artesunate sulfadoxine pyrimethamine
Chloroquine
Resistance
pfcrt
pfmdr1
url http://link.springer.com/article/10.1186/s12936-020-03274-w
work_keys_str_mv AT ashishpathak stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT andreasmartensson stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT sudhirgawariker stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT ashishsharma stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT vishaldiwan stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT manjupurohit stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia
AT johanursing stablehighfrequenciesofsulfadoxinepyrimethamineresistanceassociatedmutationsandabsenceofk13mutationsinplasmodiumfalciparum3and4yearsaftertheintroductionofartesunateplussulfadoxinepyrimethamineinujjainmadhyapradeshindia